Market Research Logo

Anti-Hypertensive Drugs

Anti-Hypertensive Drugs

Anti-Hypertensive Drugs market worldwide is projected to grow by US$3.6 Billion, driven by a compounded growth of 1.5%. Diuretics, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$11 Billion by the year 2025, Diuretics will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.9 Million to the region's size and clout in the next 5 to 6 years. Over US$111.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Diuretics will reach a market size of US$588.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 2.3% over the next couple of years and add approximately US$946.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Actelion Pharmaceuticals Ltd.; AstraZeneca PLC; Bayer AG; Boehringer Ingelheim GmbH; Daiichi Sankyo Co., Ltd.; Johnson & Johnson; Lupin Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Sanofi; Takeda Pharmaceutical Co., Ltd.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Anti-Hypertensive Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Anti-Hypertensive Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Anti-Hypertensive Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Anti-Hypertensive Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Diuretics (Type) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Diuretics (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Diuretics (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: ACE Inhibitors (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: ACE Inhibitors (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: ACE Inhibitors (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: ARBs (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: ARBs (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: ARBs (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Calcium Channel Blockers (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Calcium Channel Blockers (Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Calcium Channel Blockers (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Beta & Alpha - Adrenergic Blocker (Type) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 17: Beta & Alpha - Adrenergic Blocker (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 18: Beta & Alpha - Adrenergic Blocker (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Other Types (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
TABLE 20: Other Types (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 21: Other Types (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Anti-Hypertensive Drugs Market Share (in %) by Company: 2019 & 2025
TABLE 22: United States Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 23: Anti-Hypertensive Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
TABLE 24: United States Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
CANADA
TABLE 25: Canadian Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 26: Canadian Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
TABLE 27: Anti-Hypertensive Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
JAPAN
TABLE 28: Japanese Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 29: Anti-Hypertensive Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 30: Japanese Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
CHINA
TABLE 31: Chinese Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 32: Anti-Hypertensive Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017
TABLE 33: Chinese Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Anti-Hypertensive Drugs Market: Competitor Market Share Scenario (in %)
for 2019 & 2025
TABLE 34: European Anti-Hypertensive Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 35: Anti-Hypertensive Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 36: European Anti-Hypertensive Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 37: European Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 38: Anti-Hypertensive Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 39: European Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
FRANCE
TABLE 40: Anti-Hypertensive Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 41: French Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 42: French Anti-Hypertensive Drugs Market Share Analysis by Type:
2009 VS 2019 VS 2025
GERMANY
TABLE 43: Anti-Hypertensive Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 44: German Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 45: German Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
ITALY
TABLE 46: Italian Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 47: Anti-Hypertensive Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
TABLE 48: Italian Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
TABLE 49: United Kingdom Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 50: Anti-Hypertensive Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 51: United Kingdom Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
SPAIN
TABLE 52: Spanish Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 53: Spanish Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
TABLE 54: Anti-Hypertensive Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
RUSSIA
TABLE 55: Russian Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 56: Anti-Hypertensive Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
TABLE 57: Russian Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 58: Rest of Europe Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 59: Anti-Hypertensive Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 60: Rest of Europe Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 61: Asia-Pacific Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 62: Anti-Hypertensive Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
TABLE 63: Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 64: Anti-Hypertensive Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 65: Asia-Pacific Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 66: Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 67: Anti-Hypertensive Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 68: Australian Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 69: Australian Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
INDIA
TABLE 70: Indian Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 71: Indian Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
TABLE 72: Anti-Hypertensive Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
SOUTH KOREA
TABLE 73: Anti-Hypertensive Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 74: South Korean Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 75: Anti-Hypertensive Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 76: Rest of Asia-Pacific Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 77: Anti-Hypertensive Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 78: Rest of Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 79: Latin American Anti-Hypertensive Drugs Market Trends by Region/Country in US$ Million: 2018-2025
TABLE 80: Anti-Hypertensive Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 81: Latin American Anti-Hypertensive Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 82: Latin American Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 83: Anti-Hypertensive Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
TABLE 84: Latin American Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
TABLE 85: Argentinean Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 86: Anti-Hypertensive Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 87: Argentinean Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
BRAZIL
TABLE 88: Anti-Hypertensive Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 89: Brazilian Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
TABLE 90: Brazilian Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
MEXICO
TABLE 91: Anti-Hypertensive Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 92: Mexican Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 93: Mexican Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 94: Rest of Latin America Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 95: Anti-Hypertensive Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
TABLE 96: Rest of Latin America Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 97: The Middle East Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 98: Anti-Hypertensive Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
TABLE 99: The Middle East Anti-Hypertensive Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 100: The Middle East Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
TABLE 101: The Middle East Anti-Hypertensive Drugs Historic Market by Type in US$ Million: 2009-2017
TABLE 102: Anti-Hypertensive Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
IRAN
TABLE 103: Iranian Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
TABLE 104: Anti-Hypertensive Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
TABLE 105: Iranian Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
ISRAEL
TABLE 106: Israeli Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
TABLE 107: Anti-Hypertensive Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
TABLE 108: Israeli Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 109: Saudi Arabian Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
TABLE 110: Anti-Hypertensive Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
TABLE 111: Saudi Arabian Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
TABLE 112: Anti-Hypertensive Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 113: United Arab Emirates Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 114: Anti-Hypertensive Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 115: Anti-Hypertensive Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
TABLE 116: Rest of Middle East Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
TABLE 117: Rest of Middle East Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
AFRICA
TABLE 118: African Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
TABLE 119: Anti-Hypertensive Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
TABLE 120: African Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
IV. COMPETITION
ACTELION PHARMACEUTICALS LTD.
AMNEAL PHARMACEUTICALS
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BAYER AG
AUROBINDO PHARMA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CHIESI FARMACEUTICI SPA
CHINA PHARMA HOLDINGS
CIPLA
DAIICHI SANKYO CO., LTD.
DR. REDDY'S LABORATORIES LTD.
GILEAD SCIENCES, INC.
GLAXOSMITHKLINE PLC
GLENMARK PHARMACEUTICALS
LEXICON PHARMACEUTICALS
JOHNSON & JOHNSON
LUPIN PHARMACEUTICALS, INC.
MERCK & CO., INC.
NOVARTIS AG
NOVARTIS INTERNATIONAL AG
NOVARTIS PHARMACEUTICALS CORPORATION
PFIZER, INC
RECORDATI SPA
SANOFI
SHIONOGI & CO., LTD.
TAKEDA PHARMACEUTICAL COMPANY LIMITED
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TORAY INDUSTRIES, INC
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook